A carregar...
Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomide
The Polifeprosan 20 with carmustine (BCNU, bis-chloroethylnitrosourea, Gliadel(®)) polymer implant wafer is a biodegradable compound containing 3.85% carmustine which slowly degrades to release carmustine and protects it from exposure to water with resultant hydrolysis until the time of release. The...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3484478/ https://ncbi.nlm.nih.gov/pubmed/23118709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CE.S23244 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|